EP 1558341 A4 20100908 - TRANSCRIPTION FACTOR MODULATING COMPOUNDS AND METHODS OF USE THEREOF
Title (en)
TRANSCRIPTION FACTOR MODULATING COMPOUNDS AND METHODS OF USE THEREOF
Title (de)
TRANSKRIPTIONSFAKTOR MODULIERENDEVERBINDUNGEN UND IHRE VERWENDUNG
Title (fr)
COMPOSES MODULANT LE FACTEUR DE TRANSCRIPTION ET METHODES D'UTILISATION DE CES DERNIERS
Publication
Application
Priority
- US 0335205 W 20031103
- US 42331902 P 20021101
- US 42591602 P 20021113
Abstract (en)
[origin: WO2004041209A2] Substituted benzoimidazole compounds useful as anti-infectives that decrease resistance, virulence, or growth of microbes are provided. Methods of making and using substituted benzoimidazole compounds, as well as pharmaceutical preparations thereof, in, e.g., reducing antibiotic resistance and inhibiting biofilms.
IPC 1-7
A61P 31/00; A61K 31/55; A61K 31/495; A61K 31/50; A61K 31/535; A61K 31/44; A61K 31/41; A61K 31/425; A61K 31/415; A61K 31/42; C07D 235/00
IPC 8 full level
A61K 31/41 (2006.01); A61K 31/415 (2006.01); A61K 31/42 (2006.01); A61K 31/425 (2006.01); A61K 31/44 (2006.01); A61K 31/495 (2006.01); A61K 31/50 (2006.01); A61K 31/535 (2006.01); A61K 31/55 (2006.01); A61P 31/00 (2006.01); C07D 235/06 (2006.01); C07D 235/08 (2006.01); C07D 235/12 (2006.01); C07D 235/14 (2006.01); C07D 235/18 (2006.01); C07D 267/16 (2006.01); C07D 401/04 (2006.01); C07D 403/04 (2006.01); C07D 405/04 (2006.01); C07D 409/04 (2006.01); C07D 413/04 (2006.01); C07D 487/04 (2006.01); C07D 491/04 (2006.01); C07D 498/04 (2006.01); C07D 235/10 (2006.01)
CPC (source: EP)
A61K 31/41 (2013.01); A61K 31/415 (2013.01); A61K 31/42 (2013.01); A61K 31/425 (2013.01); A61K 31/44 (2013.01); A61K 31/495 (2013.01); A61K 31/50 (2013.01); A61K 31/535 (2013.01); A61K 31/55 (2013.01); A61P 31/00 (2017.12); A61P 31/04 (2017.12); A61P 31/06 (2017.12); A61P 31/08 (2017.12); A61P 43/00 (2017.12); C07D 235/06 (2013.01); C07D 235/08 (2013.01); C07D 235/12 (2013.01); C07D 235/14 (2013.01); C07D 235/18 (2013.01); C07D 267/16 (2013.01); C07D 401/04 (2013.01); C07D 403/04 (2013.01); C07D 405/04 (2013.01); C07D 409/04 (2013.01); C07D 413/04 (2013.01); C07D 487/04 (2013.01); C07D 491/04 (2013.01); Y02A 50/30 (2017.12)
Citation (search report)
- [X] DE 2109331 A1 19710902
- [X] US 3516999 A 19700623 - KANO HIDEO, et al
- [X] FR 2047462 A5 19710312 - HOECHST AG
- [X] US 3743738 A 19730703 - HOFF D, et al
- [X] CH 556868 A 19741213 - MERCK & CO INC
- [X] CH 554892 A 19741015 - MERCK & CO INC
- [X] DE 1545718 A1 19690710 - CIBA GEIGY
- [E] WO 2004001058 A2 20031231 - PARATEK PHARM INNC [US], et al
- [X] US 3325356 A 19670613 - DI NETTA JOSEPH, et al
- [X] BE 674202 A 19660622
- [X] MINISCI, F. ET AL.: "Addition reaction of nitrile oxides to aromatic nitroso derivatives. A novel synthesis of the benzimidazole ring", TETRAHEDRON LETTERS, no. 12, 1963, pages 785 - 790, XP002594210, ISSN: 0040-4039
- [X] DE STEVENS G ET AL: "Derivatives of 1-Hydroxybenzimidazoles and 1-Hydroxyindoles and Their Central Depressant Effects", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, WASHINGTON, US LNKD- DOI:10.1021/JM00314A018, vol. 10, no. 2, 1 March 1967 (1967-03-01), pages 211 - 214, XP002980391, ISSN: 0022-2623
- See references of WO 2004041209A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
Designated extension state (EPC)
AL LT LV MK
DOCDB simple family (publication)
WO 2004041209 A2 20040521; WO 2004041209 A3 20040930; AU 2003291226 A1 20040607; AU 2003291226 B2 20090604; CA 2504448 A1 20040521; CA 2504448 C 20120619; EP 1558341 A2 20050803; EP 1558341 A4 20100908; JP 2006513162 A 20060420; JP 2010235612 A 20101021; JP 2012131813 A 20120712; JP 5175316 B2 20130403
DOCDB simple family (application)
US 0335205 W 20031103; AU 2003291226 A 20031103; CA 2504448 A 20031103; EP 03783155 A 20031103; JP 2004550495 A 20031103; JP 2010109145 A 20100511; JP 2012039805 A 20120227